In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ChromaVision gets $5mm in private placement from Safeguard

Executive Summary

Cellular imaging company ChromaVision Medical Systems raised $5mm through the private placement of stock to life sciences incubator Safeguard Scientifics, its largest shareholder. The company sold 2.3mm common shares at $2.18 each, a 21% discount to the market average.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Cytology
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies